amlodipine has been researched along with Injury, Myocardial Reperfusion in 18 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Possibilities of secondary prevention of reperfusion syndrome with amlodipine was assessed in 46 patients (39 with class III-IV angina after myocardial infarction and 7 with non ST elevation acute coronary syndrome)." | 7.72 | [Reperfusion syndrome after direct myocardial revascularization on beating heart in patients with ischemic heart disease. Possibilities of prevention with amlodipine]. ( Akhmedov, ShD; Dzhavadova, GK; Kandinskiĭ, ML; Tepliakov, AT; Vesnina, ZhV, 2003) |
| "Possibilities of secondary prevention of reperfusion syndrome with amlodipine was assessed in 46 patients (39 with class III-IV angina after myocardial infarction and 7 with non ST elevation acute coronary syndrome)." | 3.72 | [Reperfusion syndrome after direct myocardial revascularization on beating heart in patients with ischemic heart disease. Possibilities of prevention with amlodipine]. ( Akhmedov, ShD; Dzhavadova, GK; Kandinskiĭ, ML; Tepliakov, AT; Vesnina, ZhV, 2003) |
| "Amlodipine is an intrinsically long-acting, vasoselective calcium antagonist structurally related to nifedipine, but with unique binding and pharmacologic properties that distinguish it from other agents of this class." | 2.39 | Unique pharmacologic properties of amlodipine. ( Burges, R; Moisey, D, 1994) |
| "Heart rates and ventricular arrhythmias were recorded during ischaemia/reperfusion progress." | 1.35 | Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats. ( Ahmed, LA; Attia, AS; El-Sayed, ME; Salem, HA, 2009) |
| "Hypertension is a complex disease, the treatment of which should not only lower systolic and diastolic blood pressure but also attenuate the secondary consequences of the disease." | 1.29 | End-organ involvement and calcium antagonist therapy: animal studies. ( Nayler, WG, 1994) |
| "Amlodipine pretreatment attenuated this increase in a time- and dose-dependent manner." | 1.28 | Effect of amlodipine pretreatment on ischaemia-reperfusion-induced increase in cardiac endothelin-1 binding site density. ( Casley, DJ; Gu, XH; Nayler, WG; Ou, RC, 1992) |
| "4." | 1.28 | Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol. ( Dalipram, RA; Dusting, GJ; Sobey, CG; Woodman, OL, 1992) |
| "Amlodipine is a long-acting dihydropyridine calcium antagonist with vascular selectivity." | 1.28 | Vascular and myocardial effects of amlodipine: an overview. ( Gu, XH; Nayler, WG, 1991) |
| "Amlodipine is a dihydropyridine derivative belonging to the group of pharmacologic calcium entry blocking agents and is characterized as having a slow onset and relatively long duration of action with minimal effects on cardiac electrophysiology and myocardial contractility." | 1.28 | Cardioprotective effects of amlodipine in the ischemic-reperfused heart. ( Hoff, PT; Lucchesi, BR; Tamura, Y, 1989) |
| "Amlodipine is a long-acting dihydropyridine-based Ca2+ channel blocker, developed for use on a once-daily basis." | 1.28 | Amlodipine pretreatment and the ischemic heart. ( Nayler, WG, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, LA | 1 |
| Salem, HA | 1 |
| Attia, AS | 1 |
| El-Sayed, ME | 1 |
| Khan, NA | 1 |
| Chattopadhyay, P | 1 |
| Abid, M | 1 |
| Pawdey, A | 1 |
| Kishore, K | 1 |
| Wahi, AK | 1 |
| Tepliakov, AT | 1 |
| Dzhavadova, GK | 1 |
| Akhmedov, ShD | 1 |
| Kandinskiĭ, ML | 1 |
| Vesnina, ZhV | 1 |
| Lucchesi, BR | 4 |
| Hoff, PT | 3 |
| Tamura, Y | 4 |
| Nayler, WG | 4 |
| Mehta, JL | 1 |
| Burges, R | 1 |
| Moisey, D | 1 |
| Sobey, CG | 2 |
| Dalipram, RA | 2 |
| Woodman, OL | 2 |
| Becker, BF | 1 |
| Möbert, J | 1 |
| Ou, RC | 1 |
| Gu, XH | 2 |
| Casley, DJ | 1 |
| Dusting, GJ | 1 |
| Gross, GJ | 2 |
| Farber, NE | 2 |
| Pieper, GM | 2 |
2 reviews available for amlodipine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Unique pharmacologic properties of amlodipine.
Topics: Amlodipine; Animals; Aorta; Calcium Channel Blockers; Delayed-Action Preparations; Dogs; Hypertensio | 1994 |
Cardioprotective effects of amlodipine on ischemia and reperfusion in two experimental models.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cats; Coronary Disease; Dogs; In Vitro Techniques; My | 1990 |
16 other studies available for amlodipine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats.
Topics: Amlodipine; Animals; Antioxidants; Arrhythmias, Cardiac; Cardiotonic Agents; Drug Evaluation, Precli | 2009 |
Protective effects of amlodipine on mitochondrial injury in ischemic reperfused rat heart.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Vessels; Female; Male; Mitochondria, Heart; | 2012 |
[Reperfusion syndrome after direct myocardial revascularization on beating heart in patients with ischemic heart disease. Possibilities of prevention with amlodipine].
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Echocardiography, Doppler; Elect | 2003 |
Cardioprotective effects of amlodipine in animal models of ischemia and reperfusion.
Topics: Amlodipine; Animals; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Cats; Coronary Ci | 1991 |
End-organ involvement and calcium antagonist therapy: animal studies.
Topics: Administration, Oral; Amlodipine; Animals; Aorta, Thoracic; Arteriosclerosis; Binding Sites; Blood P | 1994 |
Emerging options in the management of myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Disease | 1994 |
Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs.
Topics: Allopurinol; Amlodipine; Anesthetics; Animals; Dogs; Endothelium, Vascular; Female; Male; Myocardial | 1993 |
Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dose-Response Relati | 1999 |
Effect of amlodipine pretreatment on ischaemia-reperfusion-induced increase in cardiac endothelin-1 binding site density.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Endothelins; Female; In Vitro Techniques; Myocardial | 1992 |
Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol.
Topics: Acetylcholine; Allopurinol; Amlodipine; Animals; Calcium Channel Blockers; Coronary Disease; Coronar | 1992 |
Vascular and myocardial effects of amlodipine: an overview.
Topics: Amlodipine; Animals; Arteriosclerosis; Binding Sites; Calcium Channel Blockers; Cardiomegaly; Cerebr | 1991 |
Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cats; Dogs; Heart; In Vitro Techniques; Myocardial Co | 1989 |
Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
Topics: Amlodipine; Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Cats; Compliance; Coronary C | 1989 |
Amlodipine pretreatment and the ischemic heart.
Topics: Acidosis; Adenosine Triphosphate; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Coronary D | 1989 |
Effects of amlodipine on myocardial ischemia-reperfusion injury in dogs.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Circulation; Dogs; Energy Metabolism; Female | 1989 |
Effect of amlodipine on myocardial functional and metabolic recovery following coronary occlusion and reperfusion in dogs.
Topics: Adenine Nucleotides; Amlodipine; Animals; Calcium Channel Blockers; Coronary Disease; Coronary Vesse | 1989 |